Potential cell therapy for liver cirrhosis - Safety clinical trial

From Robin Morton on October 7th, 2019

likes views comments

Liver disease patients could one day benefit from a new macrophage cell therapy that has just completed its first clinical trial, published in Nature Medicine (07 October 2019). Professor Stuart Forbes (MRC Centre for Regenerative Medicine) describes the results of this safety clinical trial.
http://www.crm.ed.ac.uk/news/macrophage-cell-therapy-safe-trial-suggests

Videography: Jessie Pearson, Robin Morton and Ellie Roger

Tags

the university of edinburgh

The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336, VAT Registration Number GB 592 9507 00, and is acknowledged by the UK authorities as a “Recognised body” which has been granted degree awarding powers.

Unless explicitly stated otherwise, all material is copyright © The University of Edinburgh 2019. Course specific materials are created by University of Edinburgh staff for you to use in your studies. You should not share, publish or sell these outside the University

Potential cell therapy for liver cirrhosis - Safety clinical trial

Related Media

the university of edinburgh